Literature DB >> 8171022

Erythropoietin receptor mRNA expression in human endothelial cells.

A Anagnostou1, Z Liu, M Steiner, K Chin, E S Lee, N Kessimian, C T Noguchi.   

Abstract

A previous report demonstrated that endothelial cells have erythropoietin receptors and respond to this hormone with enhanced proliferation. The present study demonstrates the existence of mRNA for erythropoietin receptor in human umbilical vein endothelial cells. We have reverse transcribed mRNA of endothelial cells and then used different PCR primers to amplify erythropoietin receptor target cDNA between exons 5 and 6 as well as 3-5 in addition to an internal standard DNA fragment. Correspondence of size as well as location of restriction endonuclease scission (Ava II) was used in comparing the amplified fragments of human endothelial cell erythropoietin receptor to those of two human erythroleukemia cell lines, OCIM1 and K562. No alpha- or gamma-globin mRNA was detected in endothelial cells but was readily demonstrable in OCIM1 cells. In addition, to determine whether the expression of human erythropoietin receptor on endothelial cells occurs in vivo, sections of umbilical cord and placenta were immunostained with antibodies against the extracellular portion of the receptor; the results showed strong positive staining of the vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8171022      PMCID: PMC43705          DOI: 10.1073/pnas.91.9.3974

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Expression of the CD34 gene in vascular endothelial cells.

Authors:  L Fina; H V Molgaard; D Robertson; N J Bradley; P Monaghan; D Delia; D R Sutherland; M A Baker; M F Greaves
Journal:  Blood       Date:  1990-06-15       Impact factor: 22.113

Review 2.  Activation of the erythropoietin receptor in stable lymphoid and myeloid transfectants.

Authors:  A D D'Andrea; S S Jones
Journal:  Semin Hematol       Date:  1991-04       Impact factor: 3.851

Review 3.  Erythropoietin.

Authors:  S B Krantz
Journal:  Blood       Date:  1991-02-01       Impact factor: 22.113

4.  Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile.

Authors:  T Papayannopoulou; M Brice; V C Broudy; K M Zsebo
Journal:  Blood       Date:  1991-09-15       Impact factor: 22.113

5.  Hematopoietic development of embryonic stem cells in vitro: cytokine and receptor gene expression.

Authors:  R M Schmitt; E Bruyns; H R Snodgrass
Journal:  Genes Dev       Date:  1991-05       Impact factor: 11.361

6.  Stromal populations and fibrosis in human long-term bone marrow cultures.

Authors:  Z Z Chen; D R Van Bockstaele; N Buyssens; D Hendrics; I De Meester; G Vanhoof; S L Scharpé; M E Peetermans; Z N Berneman
Journal:  Leukemia       Date:  1991-09       Impact factor: 11.528

7.  Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours.

Authors:  I Kuzu; R Bicknell; A L Harris; M Jones; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

8.  Vascular endothelium as a regulator of granulopoiesis: production of colony-stimulating activity by cultured human endothelial cells.

Authors:  P J Quesenberry; M A Gimbrone
Journal:  Blood       Date:  1980-12       Impact factor: 22.113

9.  Quantitation of human erythroid-specific porphobilinogen deaminase mRNA by the polymerase chain reaction.

Authors:  J H Lin; B Grandchamp; N G Abraham
Journal:  Exp Hematol       Date:  1991-09       Impact factor: 3.084

10.  Expression of GATA-binding proteins during embryonic development in Xenopus laevis.

Authors:  L I Zon; C Mather; S Burgess; M E Bolce; R M Harland; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

View more
  126 in total

Review 1.  Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy.

Authors:  Cristina Hernández; Rafael Simó
Journal:  Endocrine       Date:  2011-12-14       Impact factor: 3.633

2.  Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin.

Authors:  F T Ruschitzka; R H Wenger; T Stallmach; T Quaschning; C de Wit; K Wagner; R Labugger; M Kelm; G Noll; T Rülicke; S Shaw; R L Lindberg; B Rodenwaldt; H Lutz; C Bauer; T F Lüscher; M Gassmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  GATA-binding protein 4 (GATA-4) and T-cell acute leukemia 1 (TAL1) regulate myogenic differentiation and erythropoietin response via cross-talk with Sirtuin1 (Sirt1).

Authors:  Li Wang; Yi Jia; Heather Rogers; Yun-Ping Wu; Suming Huang; Constance Tom Noguchi
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

4.  Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2.

Authors:  Yoshihiko Ikeda; Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Souheil El-Chemaly; Bernadette R Gochuico; Rose M May; Olanda M Hathaway; Shaowei Li; Ji-an Wang; Thomas N Darling; Mario Stylianou; Joel Moss
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-29       Impact factor: 5.464

Review 5.  Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models.

Authors:  Johannes Vogel; Max Gassmann
Journal:  J Physiol       Date:  2011-01-31       Impact factor: 5.182

6.  Functional conservation of erythropoietin signaling in zebrafish.

Authors:  Noëlle Paffett-Lugassy; Nelson Hsia; Paula G Fraenkel; Barry Paw; Irene Leshinsky; Bruce Barut; Nathan Bahary; Jaime Caro; Robert Handin; Leonard I Zon
Journal:  Blood       Date:  2007-06-19       Impact factor: 22.113

7.  Erythropoietin prevents endothelial dysfunction in GTP-cyclohydrolase I-deficient hph1 mice.

Authors:  Livius V dʼUscio; Anantha V R Santhanam; Zvonimir S Katusic
Journal:  J Cardiovasc Pharmacol       Date:  2014-12       Impact factor: 3.105

8.  Circulating levels of erythropoietin and its relation to arterial stiffness in patients with hypertension.

Authors:  Omer Gedikli; Abdulkadir Kiris; Caner Karahan
Journal:  Int J Clin Exp Med       Date:  2013-09-01

9.  Inhibition of mammalian muscle differentiation by regeneration blastema extract of Sternopygus macrurus.

Authors:  Hyun-Jung Kim; Eric Archer; Norma Escobedo; Stephen J Tapscott; Graciela A Unguez
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

10.  Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial.

Authors:  Yi-Da Tang; Faisal Hasan; Frank J Giordano; Stephen Pfau; Henry M Rinder; Stuart D Katz
Journal:  Am Heart J       Date:  2009-12       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.